2-31348920-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000379.4(XDH):​c.3030T>C​(p.Phe1010Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.773 in 1,612,262 control chromosomes in the GnomAD database, including 482,176 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 46008 hom., cov: 34)
Exomes 𝑓: 0.77 ( 436168 hom. )

Consequence

XDH
NM_000379.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.46

Publications

37 publications found
Variant links:
Genes affected
XDH (HGNC:12805): (xanthine dehydrogenase) Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism. [provided by RefSeq, Jan 2014]
XDH Gene-Disease associations (from GenCC):
  • xanthinuria type I
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 2-31348920-A-G is Benign according to our data. Variant chr2-31348920-A-G is described in ClinVar as Benign. ClinVar VariationId is 255968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.46 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XDHNM_000379.4 linkc.3030T>C p.Phe1010Phe synonymous_variant Exon 27 of 36 ENST00000379416.4 NP_000370.2
XDHXM_011533095.3 linkc.3027T>C p.Phe1009Phe synonymous_variant Exon 27 of 36 XP_011531397.1
XDHXM_011533096.3 linkc.3030T>C p.Phe1010Phe synonymous_variant Exon 27 of 29 XP_011531398.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XDHENST00000379416.4 linkc.3030T>C p.Phe1010Phe synonymous_variant Exon 27 of 36 1 NM_000379.4 ENSP00000368727.3

Frequencies

GnomAD3 genomes
AF:
0.777
AC:
118197
AN:
152148
Hom.:
45976
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.790
Gnomad AMI
AF:
0.898
Gnomad AMR
AF:
0.742
Gnomad ASJ
AF:
0.818
Gnomad EAS
AF:
0.847
Gnomad SAS
AF:
0.838
Gnomad FIN
AF:
0.768
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.765
Gnomad OTH
AF:
0.769
GnomAD2 exomes
AF:
0.783
AC:
196774
AN:
251254
AF XY:
0.786
show subpopulations
Gnomad AFR exome
AF:
0.792
Gnomad AMR exome
AF:
0.745
Gnomad ASJ exome
AF:
0.822
Gnomad EAS exome
AF:
0.851
Gnomad FIN exome
AF:
0.759
Gnomad NFE exome
AF:
0.769
Gnomad OTH exome
AF:
0.770
GnomAD4 exome
AF:
0.772
AC:
1127631
AN:
1459996
Hom.:
436168
Cov.:
45
AF XY:
0.775
AC XY:
562718
AN XY:
726450
show subpopulations
African (AFR)
AF:
0.787
AC:
26309
AN:
33450
American (AMR)
AF:
0.745
AC:
33295
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.828
AC:
21619
AN:
26120
East Asian (EAS)
AF:
0.858
AC:
34035
AN:
39688
South Asian (SAS)
AF:
0.846
AC:
72912
AN:
86214
European-Finnish (FIN)
AF:
0.752
AC:
40158
AN:
53404
Middle Eastern (MID)
AF:
0.793
AC:
4565
AN:
5760
European-Non Finnish (NFE)
AF:
0.764
AC:
847842
AN:
1110308
Other (OTH)
AF:
0.777
AC:
46896
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
13033
26066
39099
52132
65165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20444
40888
61332
81776
102220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.777
AC:
118281
AN:
152266
Hom.:
46008
Cov.:
34
AF XY:
0.777
AC XY:
57849
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.790
AC:
32841
AN:
41550
American (AMR)
AF:
0.741
AC:
11347
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.818
AC:
2840
AN:
3472
East Asian (EAS)
AF:
0.846
AC:
4386
AN:
5182
South Asian (SAS)
AF:
0.837
AC:
4043
AN:
4830
European-Finnish (FIN)
AF:
0.768
AC:
8140
AN:
10600
Middle Eastern (MID)
AF:
0.731
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
0.765
AC:
52027
AN:
68006
Other (OTH)
AF:
0.767
AC:
1623
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1394
2787
4181
5574
6968
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.773
Hom.:
216184
Bravo
AF:
0.778
Asia WGS
AF:
0.796
AC:
2767
AN:
3478
EpiCase
AF:
0.771
EpiControl
AF:
0.776

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Hereditary xanthinuria type 1 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Xanthinuria type II Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
8.6
DANN
Benign
0.71
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1884725; hg19: chr2-31571786; COSMIC: COSV108235514; API